Join to View Full Profile
3601 The Vanderbilt ClinicNashville, TN 37232
Phone+1 615-322-3000
Dr. Agarwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rajiv Agarwal is an oncologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. He received his medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 7 years. He specializes in gastrointestinal cancer and hospice & palliative. He has more than 20 publications and over 100 citings.
Education & Training
Vanderbilt University School of MedicineMasters Degree, Clinical Investigation, 2019 - 2021
Memorial Sloan Kettering Cancer CenterFellowship, Hospice and Palliative Medicine, 2018 - 2019- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2018
Duke University HospitalResidency, Internal Medicine, 2014 - 2016
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2013, MD
Columbia UniversityBA, Philosophy, 2005 - 2009
Certifications & Licensure
TN State Medical License 2019 - 2027
NY State Medical License 2016 - 2019
NC State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Design and Implementation of a Primary Palliative Care Education Program for Hematology-Oncology Advanced Practice Providers: Insights from a Three-Year Cohort.Olivia C West, Catherine McCarty, Rajiv Agarwal, Mohana Karlekar
Journal of Pain and Symptom Management. 2025-08-05 - Teaching Communication Skills and Developing Comfort With Difficult Conversations: A Combined Palliative Care-Oncology Simulation Session for Hematology/Oncology Fellows.Megan M Dupuis, Katherine J Walsh, Rajiv Agarwal
JCO Oncology Practice. 2025-07-29 - S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE).Anwaar Saeed, Sarah Colby, Paul Eliezer Oberstein, Dan G Duda, Robin Park
Future Oncology. 2025-05-01
Press Mentions
Finerenone and Empagliflozin Combo Significantly Reduces Albuminuria in CKD with T2D: New Data from CONFIDENCE TrialJune 6th, 2025- Only Half of Young Cancer Patients Report a Discussion on Fertility PreservationNovember 12th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
